A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors.

@article{Theodore2008API,
  title={A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors.},
  author={Christine A Theodore and Christine Chevreau and Y Yataqhene and Karim S Fizazi and J. P. Delord and Jean-pierre Lotz and Lionnel Geoffrois and Pierre Kerbrat and V Bang Bui and Aude Fl{\'e}chon},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2008},
  volume={19 8},
  pages={1465-9}
}
BACKGROUND The aim of this study is to determine feasibility and efficacy of the combination regimen oxaliplatin and paclitaxel in patients with cisplatin (CDDP)-refractory germ-cell tumors (GCT). PATIENTS AND METHODS Patients with either a cisplatin absolute-refractory GCT defined as progressive disease (PD) during or within 1 month of CDDP administration or with a poor prognosis relapse, defined as PD between the second and the sixth month after CDDP administration, were treated with a… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Phase II trial of gemcitabine in refractory germ cell tumors

  • LH Einhorn, MJ Stendler, SD. Williams
  • J Clin Oncol
  • 1999
Highly Influential
6 Excerpts

Similar Papers

Loading similar papers…